OPPM
BHVN

Opus Point Partners Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Opus Point Partners Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$453K Hold
10,852
– – 0.82% 31
2019
Q2 		$475K Hold
10,852
– – 0.7% 36
2019
Q1 		$559K Buy
+10,852
New +$469K 0.76% 28

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Opus Point Partners Management's BHVN Position: Q3 2019 in Review

Opus Point Partners Management held its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) position steady in Q3 2019 at 10,852 shares worth $453K. The position accounts for 0.82% of the portfolio, ranked #31.

Opus Point Partners Management first reported a position in BHVN in Q1 2019 and has held it in 3 quarters since. The position peaked at $559K in Q1 2019. 184 funds tracked by Wall St. Rank hold BHVN as of Q3 2019.

  • Opus Point Partners Management held 10,852 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $453K as of Q3 2019.
  • Opus Point Partners Management left its Biohaven Pharmaceutical Holding Company Ltd. share count unchanged in Q3 2019.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 0.82% of Opus Point Partners Management's portfolio in Q3 2019, its #31 holding.
  • Opus Point Partners Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and has held it in 3 quarters since.
  • Opus Point Partners Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $559K in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.